MOLECULAR INSIGHTS AND GENETIC IMPLICATIONS IN PARKINSONISM-DEMENTIA-AMYOTROPHIC LATERAL SCLEROSIS COMPLEX: A CASE REPORT
Main Article Content
Keywords
Parkinsonism, Dementia, Amyotrophic Lateral Sclerosis, Neurodegenerative Disease
Abstract
Introduction: The parkinsonism-dementia-amyotrophic lateral sclerosis complex was first described in the islands of Guam, with its peak incidence in the 1950s. Due to its rarity, we present a clinical case to shed light on this association. The objective is to describe the nosological and pathogenetic implications of this neurodegenerative disease, particularly in populations where this association is unexpected.
Clinical Case: We report a case of Pakistani origin with systemic symptoms evolving over 5 years, followed by cognitive alterations. Subsequently, the patient developed gait disturbances and motor symptoms suggestive of parkinsonism with atypical features and signs of motor neuron disease. Extension studies confirmed the involvement of both upper and lower motor neurons, with a mutation observed in the POLG gene associated with mitochondrial depletion syndrome.
Conclusion: Despite being a known association, diagnosis of this entity remains challenging clinically. Molecular mechanisms have not been fully elucidated; common genes associated with parkinsonism and amyotrophic lateral sclerosis have been ruled out, with attempts to localize the locus yielding inconclusive results. Unfortunately, the prognosis remains fatal, and there are currently no disease-modifying treatments available.
References
2. Aubrey, L. D., Ninkina, N., Ulamec, S. M., Abramycheva, N. Y., Vasili, E., Devine, O. M., . . . Walko, M. (2024). Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. Proceedings of the National Academy of Sciences, 121(2), e2309700120.
3. Bartók, Á., & Csanády, L. (2024). TRPM2-an adjustable thermostat. Cell Calcium, 102850.
4. Baskerville, V., Rapuri, S., Mehlhop, E., & Coyne, A. N. (2024). SUN1 facilitates CHMP7 nuclear influx and injury cascades in sporadic amyotrophic lateral sclerosis. Brain, 147(1), 109-121.
5. Bhatt, N., Puangmalai, N., Sengupta, U., Jerez, C., Kidd, M., Gandhi, S., & Kayed, R. (2024). C9orf72 Associated Dipeptide Protein Repeats Form A11-positive Oligomers in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Journal of Biological Chemistry, 105628.
6. Candeias, E., Nunes-Costa, D., Pereira-Santos, A. R., Magalhães, J. D., Melo-Marques, I., Guedes, B., . . . Cardoso, S. M. (2024). Neurotoxicity induced by the microbial metabolite β-methylamino-L-alanine: pathways and mechanisms Natural Molecules in Neuroprotection and Neurotoxicity (pp. 747-778): Elsevier.
7. Carmona, A., Carboni, E., Gomes, L. C., Roudeau, S., Maass, F., Lenz, C., . . . Lingor, P. (2024). Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis. Journal of Neurochemistry.
8. Chen, K., Gao, T., Liu, Y., Zhu, K., Wang, T., & Zeng, P. (2024). Identifying risk loci for FTD and shared genetic component with ALS: A large-scale multitrait association analysis. Neurobiology of Aging, 134, 28-39.
9. da Silva, I. S., Cardoso, A. R., & Sales, M. G. F. (2024). Electrochemical biosensor-based detection assays for early diagnosis of neurodegenerative disorders Smart Diagnostics for Neurodegenerative Disorders (pp. 155-177): Elsevier.
10. De Marchi, F., Venkatesan, S., Saraceno, M., Mazzini, L., & Grossini, E. (2024). Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: Current evidence and potential use. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
11. Gallo, S., Vignaroli, F., Contaldi, E., Vecchio, D., Corrado, L., D'Alfonso, S., . . . Magistrelli, L. (2024). Parkinson's disease and chronic inflammatory demyelinating polyneuropathy: Broadening the clinical spectrum of VCP mutations. Parkinsonism & Related Disorders, 118.
12. Goswami, A., & Carra, S. (2024). PML nuclear bodies: new players in familial amyotrophic lateral sclerosis-frontotemporal dementia? Neural Regeneration Research, 10.4103.
13. Hartopp, N., Markovinovic, A., Miller, C. C., & Gomez-Suaga, P. (2024). Insight into endoplasmic reticulum-mitochondria contacts in human amyotrophic lateral sclerosis. Neural Regeneration Research, 19(7), 1407-1408.
14. Huo, D., Liang, W., Wang, D., Liu, Q., Wang, H., Wang, Y., . . . Tan, X. (2024). Roflupram alleviates autophagy defects and reduces mutant hSOD1-induced motor neuron damage in cell and mouse models of amyotrophic lateral sclerosis. Neuropharmacology, 109812.
15. Iskusnykh, I. Y., Zakharova, A. A., Kryl’skii, E. D., & Popova, T. N. (2024). Aging, Neurodegenerative Disorders, and Cerebellum. International Journal of Molecular Sciences, 25(2), 1018.
16. Jeong, S. H., Cha, J., Yoo, H. S., Chung, S. J., Jung, J. H., Sohn, Y. H., & Lee, P. H. (2024). Different effect of hypo-and hypermetabolism on cognition in dementia with Lewy bodies: are they coupled or independent? npj Parkinson's Disease, 10(1), 4.
17. Jia, F., Zhang, B., Yu, W., Chen, Z., Xu, W., Zhao, W., & Wang, Z. (2024). Exploring the cuproptosis-related molecular clusters in the peripheral blood of patients with amyotrophic lateral sclerosis. Computers in Biology and Medicine, 168, 107776.
18. Klíčová, K., Mareš, J., Menšíková, K., Kaiserová, M., Friedecký, D., Kaňovský, P., . . . Matěj, R. (2024). Utilizing neurodegenerative markers for the diagnostic evaluation of amyotrophic lateral sclerosis. European Journal of Medical Research, 29(1), 1-9.
19. Kwon, Y., Kang, M., Jeon, Y.-M., Lee, S., Lee, H.-W., Park, J.-S., & Kim, H.-J. (2024). Identification and characterization of novel ERBB4 variant associated with sporadic amyotrophic lateral sclerosis (ALS). Journal of the Neurological Sciences, 122885.
20. Leonard, H., Jonson, C., Levine, K., Lake, J., Hertslet, L., Jones, L., . . . Terry, N. (2024). Assessing the lack of diversity in genetics research across neurodegenerative diseases: a systematic review of the GWAS Catalog and literature. medRxiv, 2024.2001. 2008.24301007.
21. Liu, S., Sun, X., Ren, Q., Chen, Y., Dai, T., Yang, Y., . . . Meng, X. (2024). Glymphatic dysfunction in patients with early-stage amyotrophic lateral sclerosis. Brain, 147(1), 100-108.
22. Mahin, A., Soman, S. P., Modi, P. K., Raju, R., Keshava Prasad, T. S., & Abhinand, C. S. (2024). Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 and Alzheimer's/Parkinson's diseases. Journal of NeuroVirology, 1-14.
23. Manera, U., Matteoni, E., Canosa, A., Callegaro, S., Casale, F., Marchis, D., . . . Calvo, A. (2024). Mycotoxins and Amyotrophic Lateral Sclerosis: food exposure, nutritional implications and dietary solutions. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders).
24. Martinelli, I., Zucchi, E., Simonini, C., Gianferrari, G., Bedin, R., Biral, C., . . . Mandrioli, J. (2024). SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study. European Journal of Neurology, 31(1), e16054.
25. Morrow, C. B. (2024). Geriatric Psychiatry and the Future of Dementia Care: Diagnosing TDP-43 Neurodegenerative Disease. The American Journal of Geriatric Psychiatry, 32(1), 114-116.
26. Neubrand, V. E., Sepúlveda, M. R., Dias, C., Nylandsted, J., Gothié, J.-D. M., Kennedy, T. E., . . . Torii, T. (2024). 1421 A dysregulated calcium homeostasis as the earliest pathological sign in stem cell-derived Parkinson’s disease neurons? Neural Regeneration Research, 19(7), 1393.
27. Payne, T., Burgess, T., Bradley, S., Roscoe, S., Sassani, M., Dunning, M. J., . . . Taylor, R. (2024). Multimodal assessment of mitochondrial function in Parkinson's disease. Brain, 147(1), 267-280.
28. Sofyantoro, F., Frediansyah, A., Putri, W. A., Adipuri, W., Ramadaningrum, F. N., & Sharma, R. (2024). 10 Herbal Medicines. Nanoarchitectonics for Brain Drug Delivery, 210.
29. Tsuji, K., Nakayama, Y., Taruya, J., & Ito, H. (2024). Persistence of Kii amyotrophic lateral sclerosis after the 2000s and its characteristic aging-related tau astrogliopathy. Journal of Neuropathology & Experimental Neurology, nlad113.
30. Wang, H., Liu, Y.-T., Ren, Y.-L., Guo, X.-Y., & Wang, Y. (2024). Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis. Journal of Neuroimmunology, 578290.
31. Wang, Y., Liu, L., Chen, H., Yang, Y., Mu, C., Ren, H., . . . Wang, G. (2024). Disrupted phase behavior of FUS underlies poly-PR-induced DNA damage in amyotrophic lateral sclerosis. Human Molecular Genetics, 33(1), 64-77.
32. Wu, F., Malek, A. M., Buchanich, J. M., Arena, V. C., Rager, J. R., Sharma, R. K., . . . Talbott, E. O. (2024). Exposure to ambient air toxicants and the risk of amyotrophic lateral sclerosis (ALS): A matched case control study. Environmental Research, 242, 117719.
33. Xiang, Y., Huang, X., Xu, Q., Liu, Z., Chen, Y., Sun, Q., . . . Yan, X. (2024). Estimating the sequence of biomarker changes in Parkinson's disease. Parkinsonism & Related Disorders, 118, 105939.
34. Xuan, X., Zheng, G., Zhu, W., Sun, Q., Zeng, Y., Du, J., & Huang, X. (2024). Alterations in regional homogeneity and functional connectivity in the cerebellum of patients with sporadic amyotrophic lateral sclerosis. Behavioural Brain Research, 458, 114749.
35. Young, A. L., Oxtoby, N. P., Garbarino, S., Fox, N. C., Barkhof, F., Schott, J. M., & Alexander, D. C. (2024). Data-driven modelling of neurodegenerative disease progression: thinking outside the black box. Nature Reviews Neuroscience, 1-20.
36. Yu, W., Yu, F., Li, M., Yang, F., Wang, H., Song, H., & Huang, X. (2024). Quantitative association between lead exposure and amyotrophic lateral sclerosis: a Bayesian network-based predictive study. Environmental Health, 23(1), 2.